These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23966167)

  • 1. Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells.
    Hiroshima Y; Zhao M; Zhang Y; Maawy A; Hassanein MK; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    Cell Cycle; 2013 Sep; 12(17):2774-80. PubMed ID: 23966167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX).
    Hiroshima Y; Zhao M; Maawy A; Zhang Y; Katz MH; Fleming JB; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Cell Biochem; 2014 Jul; 115(7):1254-61. PubMed ID: 24435915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.
    Kawaguchi K; Miyake K; Zhao M; Kiyuna T; Igarashi K; Miyake M; Higuchi T; Oshiro H; Bouvet M; Unno M; Hoffman RM
    Cell Cycle; 2018; 17(16):2019-2026. PubMed ID: 29963961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li S; Han Q; Tan Y; Zhao M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    Cell Cycle; 2018; 17(6):801-809. PubMed ID: 29374999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.
    Yano S; Takehara K; Zhao M; Tan Y; Han Q; Li S; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2016 Jul; 15(13):1715-23. PubMed ID: 27152859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models.
    Hiroshima Y; Zhang Y; Murakami T; Maawy A; Miwa S; Yamamoto M; Yano S; Sato S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Zhao M; Hoffman RM
    Oncotarget; 2014 Dec; 5(23):12346-57. PubMed ID: 25402324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy.
    Yano S; Zhang Y; Zhao M; Hiroshima Y; Miwa S; Uehara F; Kishimoto H; Tazawa H; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2014; 13(24):3958-63. PubMed ID: 25483077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
    Hoffman RM
    Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methioninase Cell-Cycle Trap Cancer Chemotherapy.
    Hoffman RM; Yano S; Igarashi K
    Methods Mol Biol; 2019; 1866():133-148. PubMed ID: 30725413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP).
    Miyake K; Kiyuna T; Miyake M; Zhao M; Wangsiricharoen S; Kawaguchi K; Zhang Z; Higuchi T; Razmjooei S; Li Y; Nelson SD; Russell T; Singh A; Murakami T; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Singh SR; Chawla SP; Eilber FC; Endo I; Hoffman RM
    Tissue Cell; 2018 Oct; 54():144-149. PubMed ID: 30309504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.
    Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for Tumor Targeting with Salmonella typhimurium A1-R.
    Hoffman RM; Zhao M
    Methods Mol Biol; 2016; 1409():143-64. PubMed ID: 26846809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model.
    Yamamoto M; Zhao M; Hiroshima Y; Zhang Y; Shurell E; Eilber FC; Bouvet M; Noda M; Hoffman RM
    PLoS One; 2016; 11(8):e0160882. PubMed ID: 27500926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model.
    Kiyuna T; Tome Y; Murakami T; Miyake K; Igarashi K; Kawaguchi K; Oshiro H; Higuchi T; Miyake M; Sugisawa N; Zhang Z; Razmjooei S; Wangsiricharoen S; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Eckardt MA; Singh AS; Chawla S; Kanaya F; Eilber FC; Singh SR; Zhao M; Hoffman RM
    Biochem Biophys Res Commun; 2018 Nov; 505(3):733-739. PubMed ID: 30292411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella typhimurium A1-R and Cell-Cycle Decoy Therapy of Cancer.
    Hoffman RM; Yano S
    Methods Mol Biol; 2016; 1409():165-75. PubMed ID: 26846810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Targeting Salmonella typhimurium A1-R: An Overview.
    Hoffman RM
    Methods Mol Biol; 2016; 1409():1-8. PubMed ID: 26846797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.
    Igarashi K; Kawaguchi K; Murakami T; Kiyuna T; Miyake K; Nelson SD; Dry SM; Li Y; Yanagawa J; Russell TA; Singh AS; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jun; 16(12):1164-1170. PubMed ID: 28494180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice.
    Zhang Y; Zhang N; Zhao M; Hoffman RM
    Oncotarget; 2015 Jun; 6(16):14625-31. PubMed ID: 25714030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model.
    Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Zhang Y; Zhao M; Li Y; Bouvet M; Kanaya F; Singh A; Dry S; Eilber FC; Hoffman RM
    Oncotarget; 2016 May; 7(22):33046-54. PubMed ID: 27105519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models.
    Toneri M; Miwa S; Zhang Y; Hu C; Yano S; Matsumoto Y; Bouvet M; Nakanishi H; Hoffman RM; Zhao M
    Oncotarget; 2015 Oct; 6(31):31335-43. PubMed ID: 26431498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.